We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood and Laboratory Solutions Licensed by German University

By LabMedica International staff writers
Posted on 22 Apr 2009
A German University clinic has licensed a blood information system and laboratory information system for its blood center.

EdgeBlood is the leading Blood Center management system used in France. More...
It is also used to process more than half the blood drawn in Germany as well as processing significant parts of the Austrian and Swiss blood supplies. EdgeBlood is used in Greece as well as five African countries. EdgeBlood has an easy-to-use Windows graphical user interface and contains all major functionality needed by a blood center from donor recruitment through product distribution.

EdgeLab has become the leading Laboratory Information Management System (LIMS) in Europe and is used in more than 150 licensed laboratories. EdgeLab is connected with more than 1,000 analyzers and interchanges data with all major hospital healthcare software packages. It has a vibrant, easy-to-use Windows graphical interface in addition to a comprehensive range of laboratory functionality. EdgeLab can be easily configured to meet the business needs of large, diverse, multisite hospital laboratories, as well as small, single site hospitals.

GLI (Alzey, Germany) is the German division of Global Med Technology's Inlog subsidiary. The two systems, EdgeBlood and EdgeLab, have been licensed by the University of Saarland Clinic Blood Center (Homburg, Germany) from GLI. The systems will be deployed on 25 workstations in the blood center and laboratory. Up to 50 remote users will access the Web result server EdgeNet. Five analyzers will be connected to EdgeLab, Inlog's Laboratory Information System. The blood center collects 30,000 whole blood donations per year.

"After detailed market research, the University Medical Center of Saarland has decided to install the LIS EdgeBlood/EdgeLab from the company, GLI. This decision was made because, among other reasons, the system can completely control the management of all essential services in transfusion medicine. Moreover, the software is already in use in the National German Red Cross Blood Donation Services. It has also been used successfully in comparable university facilities for many years. In view of the connection between pharmaceutical and clinical aspects of transfusion medicine, EdgeBlood and EdgeLab will create a center of excellence for the University Medical Center of Saarland," stated Prof. Dr. med. Hermann Eichler of the Institute of Clinical Hemostaseology and Transfusion Medicine Homburg/University Medical Center of Saarland.

Related Links:

GLI
University of Saarland Clinic Blood Center



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.